47‑year‑old male: among inpatients 42–52 with diabetes + acute HF, report % prevalence antidiabetic classes Insulin, Metformin, Sulfonylurea, DPP‑4, SGLT2, GLP‑1, TZD in first 24h vs final 12h, net change (pp).
